Amid a capital winter and the transmission of pressure from the secondary market to the primary market, 2022 was a year of ups and downs for China’s precision diagnosis and treatment sector, marked by both excitement and disillusionment. What significant changes occurred in the personalized diagnosis and treatment industry in 2022? What new trends deserve attention in 2023? How can we seize the new opportunities behind these changes?
In light of this, the 7th Future Healthcare Top 100 Conference has specially established the Forum on Innovative Development in Personalized Diagnosis and Treatment, bringing together industry experts, innovative enterprises, and investment institutions to jointly discuss the advancement of personalized diagnosis and treatment based on individual genetic profiles. The forum aims to promote the enhancement of diagnostic and therapeutic technologies in the personalized medicine sector, provide patients with more efficient and cost-effective care solutions, and contribute to the realization of Healthy China.


2023 Future Healthcare 100 Conference, hosted by VB100, VCBeat, and Eggshell Research Institute, with strategic partnership support from Shanghai Zhangjiang Group, will be grandly held at the Shanghai Zhangjiang Science Hall from May 5–7, 2023. Led by Academician Robert Langer and IEEE scientists, nearly 500 industry leaders will convene for three main forums and 31 hot-topic forums.